|
2671 |
Rheumatoide Arthritis
Enthalten in Zeitschrift für Rheumatologie Bd. 76, 5.1.2017, Nr. 1, date:2.2017: 8-14
|
|
|
|
2672 |
Rheumatoide Arthritis: Oraler JAK-Inhibitor bremst auch die Gelenkzerstörung
Enthalten in Orthopädie & Rheuma Bd. 21, 21.2.2018, Nr. 1, date:2.2018: 58
|
|
|
|
2673 |
Rheumatologen-Mangel macht erfinderisch
Enthalten in Orthopädie & Rheuma Bd. 20, 11.12.2017, Nr. 6, date:12.2017: 14-15
|
|
|
|
2674 |
Rheumatology around the world: perspectives from Australia and New Zealand
Enthalten in Arthritis Research & Therapy Bd. 19, 10.2.2017, Nr. 1, date:12.2017: 1-3
|
|
|
|
2675 |
Rheumatology in Africa—challenges and opportunities
Enthalten in Arthritis Research & Therapy Bd. 19, 7.3.2017, Nr. 1, date:12.2017: 1-3
|
|
|
|
2676 |
Rheumatology in the Middle East in 2017: clinical challenges and research
Enthalten in Arthritis Research & Therapy Bd. 19, 30.6.2017, Nr. 1, date:12.2017: 1-3
|
|
|
|
2677 |
Rich but poor: life in the Roman period with extreme rheumatoid arthritis
Enthalten in Clinical rheumatology Bd. 36, 26.11.2016, Nr. 1, date:1.2017: 235-238
|
|
|
|
2678 |
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis
Enthalten in Arthritis Research & Therapy Bd. 19, 24.7.2017, Nr. 1, date:12.2017: 1-7
|
|
|
|
2679 |
Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
Enthalten in Arthritis Research & Therapy Bd. 19, 24.10.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
2680 |
Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
Enthalten in BMC nephrology Bd. 18, 15.2.2017, Nr. 1, date:12.2017: 1-8
|
|
Administration
